2011-02-07T11:01:20-06:00 2010-09-30 AKT LLP 312 S Juniper Street Suite 100 Escondido CA 92025 990 2009-10-01 330189397 Veterans Medical Research Foundation Of San Diego VETE 8585527406 3350 La Jolla Village Dr Bldg 13 No MC151A San Diego CA 92161 KERSTIN LYNAM 8585527406 2011-01-26 1 Elsa A Romero 7607461560 2011-01-26 2009 2016-02-24 21:20:13Z KERSTIN LYNAM 3350 La Jolla Village Dr Bldg 13 No MC151A San Diego CA 92161 27785039 0 X WWW.VRMF.ORG and www.vmrf.net X 1989 CA to enhance the health of veterans of all generations through research and education. 15 14 342 1 0 0 18020788 19510411 6787043 8242260 7097 5728 22042 -340 24836970 27758059 0 0 15876574 16623326 22103 29217 9626172 10564608 25502746 27210037 -665776 548022 9976629 11095732 4274511 4845155 5702118 6250577 HONORING MILITARY SERVICE WITH SCIENCE; OUR "BENCH-TO-BEDSIDE" APPROACH HAS LED TO BREAKTHROUGHS IN AREAS SUCH AS SHINGLES PREVENTION, HEART DISEASE, METABOLIC DISEASES AND GROUND BREAKING WORK ON POST TRAUMATIC STRESS DISORDER (PTSD).THOSE WHO COURAGEOUSLY SERVE IN OUR NATION'S MILITARY DESERVE EXCEPTIONAL CARE. THE VETERANS MEDICAL RESEARCH FOUNDATION'S MISSION IS TO ENHANCE THE HEALTH OF VETERANS OF ALL GENERATIONS THROUGH RESEARCH AND EDUCATION. 0 0 2005163 2005163 Cardiac Gene Transfer of AC & Mechanisms for Effects Program: Dr. Kirk Hammond is directing a chronic heart failure gene transfer study which is aimed at helping patients to regenerate proteins responsible for efficient heart functions. The anticipated study results will lead to a prolonged and healthier life for the 5 million chronic heart failure patients in the USA alone. 1900638 2321600 Metabolic Effects of Newer Antipsychotics in Older PatientS:Drs. Robert Henry and Sunder Mudaliar are involved in testing a new drug called Pasireotide. This novel drug is being developed to treat Cushing's disease which affects about 15 patients per million per year and is associated with significant morbidity and mortality. Currently the treatment of choice for Cushing's disease is surgery or injectable octreotide. When patients fail these treatments, radiation is used, but is not always helpful. Pasireotide is thought of as a potential excellent second line treatment for Cushing's disease. However, in some patients, Pasireotide causes hyperglycemia and overt diabetes. This Veterans Medical Research Foundation (vmrf) study has been done to shed light on the mechanism by which Pasireotide increases blood sugar levels. 731677 731677 Dilip Jeste, MD EVALUATED FOUR commonly used medications for treating psychosis in older patients to determine the impact of side effects on everyday functioning and quality of life. This large study is the first one of its kind in older people, supported by the National Institutes of Health. Psychosis is a serious mental illness in older people. The medications used to treat it are somewhat helpful, but unfortunately, they can cause obesity, diabetes, stroke, and even death. This research, conducted under the auspices of VMRF, will help decide which particular medications are useful or harmful for specific groups of patients, and will thus have a major public health significance for treating the rapidly growing numbers of older people in the community. 16141550 3183820 (Other Program Services) The Veterans Medical Research Foundation of San Diego is the region's only medical research institution dedicated to Veterans. We facilitate world-class research at the VA San Diego Healthcare System that provides better patient care and health for Veterans with medical advances that extend to the entire population and raise the standard for care for everyone. 16141550 3183820 20779028 1 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 1 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 126 0 1 342 1 0 0 0 0 0 1 1 0 0 0 15 14 0 0 0 0 0 1 1 1 1 0 0 1 1 1 1 1 1 1 1 0 CA X EILEEN VINNOLA CONTROLLER 8585528585 3350 LA JOLLA VILLAGE DRIVE SAN DIEGO CA 92161 ROBERT ENGLER MD 1.00 X 0 0 0 GARY FIRESTEIN MD 1.00 X 0 0 0 ERIC GRANHOLM PHD 1.00 X 0 0 0 KENNETH JORDAN USMC RET 1.00 X 0 0 0 STAN JOHNSON 1.00 X 0 0 0 TODD LEIGH JD 1.00 X 0 0 0 URBAN MIYARES 1.00 X 0 0 0 ELAINE MUCHMORE MD 1.00 X X 0 0 0 JACK NAGAN JD 1.00 X 0 0 0 GERHARD SCHULTEIS PHD 1.00 X 0 0 0 ROBERT SMITH MD 1.00 X 0 0 0 HOWARD SMITH PHD 1.00 X 0 0 0 ROGER G SPRAGG MD 10.00 X X 46793 0 4751 MARK TUSZYNSKI MD PHD 1.00 X 0 0 0 JOHN WHALEN 1.00 X 0 0 0 phillip l jelsma 1.00 X X 0 0 0 BARBARA DOVENBARGER 40.00 X X 160885 0 18294 KERSTIN LYNAM 40.00 X X 241651 0 40582 maria sittmann 40.00 X 139441 0 25005 chun-ming huang 40.00 X 156553 0 27485 robert millington 40.00 X 118591 0 16076 tami penner 25.00 X 102454 0 20329 966368 0 152522 6 0 1 0 Covance Central Laboratory Services LP 8211 SCICOR DRIVE Indianapolis IN 46214 clinical trial/laboratory services 691801 Regents of the University of California 9500 Gilman Drive LA JOLLA CA 92093 research services 323693 TKL Research Inc 365 W Passaic St Rochelle Park NJ 07662 clinical trial services 156650 3 17418 19394600 98393 9043 19510411 clinical research reve 541700 5270157 5270157 GRANT REVENUE 541700 1616662 1616662 recharge income 541700 1331369 1331369 OTHER INCOME 541700 24072 24072 8242260 5728 5728 26640 17418 26980 -340 -340 27758059 8242260 0 5388 696807 696807 13669781 11460868 2208913 591811 431121 160690 998513 660745 337768 666414 490218 176196 1190325 487091 703171 63 29815 29815 53690 53690 1095 1095 22103 22103 4524789 4093801 429108 1880 31906 31906 2291707 2240935 50722 50 520801 140105 380497 199 135573 10578 124995 200840 160726 40088 26 194477 93524 99080 1873 618877 5005 613872 140197 140197 other expenses 433186 312978 119968 240 postage 113440 100737 12667 36 Printing/Copying and Pu 47820 33800 11273 2747 telephone 36070 24890 11180 0 27210037 20779028 6401792 29217 3303519 876280 1102535 5493956 3498011 3009530 7362701 5753322 1964244 1609379 108320 106587 9976629 11095732 2274797 2221686 1999714 2623469 4274511 4845155 X 5253982 5841183 448136 409394 5702118 6250577 9976629 11095732 X 0 1 1 X 1 1 X 17117958 18183307 19824574 18020788 19510411 92657038 17117958 18183307 19824574 18020788 19510411 92657038 92657038 68031 47976 72627 7097 5728 201459 3779 163907 27954 24380 220020 93078517 42617553 0.99550 X 5747970 4481079 1266891 1614731 1272243 342488 1609379 27758059 27210037 548022 437 437 548459 27785476 437 26980 27417 27758059 0 27758059 27237017 26980 26980 27210037 0 27210037 Part XII, Line 2d - Other Adjustments: special event expense netted with revenue: 26980. Part XIII, Line 2d - Other Adjustments: special event expense netted with revenue: 26980. X X X X X 1 NUFFER SMITH AND TUCKER professional fundraising 0 0 0 22103 22103 2010 vmrf honoring service gala 42748 16108 26640 1563 11364 6625 5620 VETERANS DAY CAMPAIGN 1310 1310 1808 44058 17418 26640 1563 11364 6625 7428 26980 -340 X X X X X 0 0 0 0 0 0 0 0 0 BARBARA DOVENBARGER 160885 0 0 0 0 0 16037 0 2257 0 179179 0 171924 0 KERSTIN LYNAM 235967 0 5000 0 684 0 24838 0 15744 0 282233 0 268318 0 maria sittmann 139441 0 0 0 0 0 14203 0 10802 0 164446 0 153898 0 chun-ming huang 156553 0 0 0 0 0 15831 0 11654 0 184038 0 164485 0 Form 990, Part VI, Section A, line 7a THE VETERANS MEDICAL RESEARCH FOUNDATION BOARD OF DIRECTORS INCLUDES FOUR (4) MANDATORY BOARD MEMBERS REPRESENTING THE VA SAN DIEGO HEALTHCARE SYSTEM (VASDHS). THESE MEMBERS ARE THE VASDHS DIRECTOR, CHIEF OF STAFF, ASSOCIATE CHIEF OF STAFF FOR RESEARCH AND DEVELOPMENT, AND THE ASSOCIATE CHIEF OF STAFF FOR EDUCATION. ALL OF THESE VASDHS LEADERS ARE ULTIMATELY HIRED AND APPROVED BY THE DEPARTMENT OF VETERANS AFFAIRS VETERANS HEALTH ADMINISTRATION. Form 990, Part VI, Section A, line 7b THE VETERANS MEDICAL RESEARCH FOUNDATION'S BOARD MEMBERS MUST BE SPECIFICALLY APPROVED BY THE DIRECTOR OF VASDHS. THE DIRECTOR OF THE VASDHS IS A VOTING MEMBER OF THE VMRF BOARD OF DIRECTORS AND HAS THE SAME VOTING RIGHTS AS ALL OTHER VOTING MEMBERS. Form 990, Part VI, Section B, line 11 AFTER INITIAL REVIEW BY THE CEO, CFO, AND THE CONTROLLER, THE AUDITORS REVIEW THE 990 WITH THE FINANCE COMMITTEE. THE 990 IS THEN DISTRIBUTED TO THE BOARD PRIOR TO FINAL APPROVAL BY THE CEO. Form 990, Part VI, Section B, line 12c MEMBERS OF THE BOARD OF DIRECTORS AND EXECUTIVE OFFICERS ARE REQUIRED TO COMPLETE AND SIGN A COI DISCLOSURE QUESTIONNAIRE(INCLUDING DISCLOSURE PERTAINING TO SPOUSE OR DEPENDENT CHILD(REN)) AND TO SIGN A VMRF COI AFFIRMATION OF COMPLIANCE STATEMENT. VMRF'S POLICY ON COI INCLUDES DISCLOSURE REQUIREMENTS, PROCEDURES FOR REVIEW OF POTENTIAL CONFLICTS AND ADDRESSING CONFLICTS OF INTERESTS, AS WELL AS PROVISIONS ON WHAT DISCIPLINARY ACTIONS TO TAKE IN CASE OF VIOLATIONS OF THE BOARD APPROVED COI POLICY. INTERESTED PARTIES WITH A POTENTIAL COI RE: PROPOSED ACTION, POLICY, OR TRANSACTION OF VMRF SHALL NOT PARTICIPATE IN ANY WAY OR BE PRESENT DURING THE DELIBERATION AND DECISION-MAKING FOR SUCH ACTION. Form 990, Part VI, Section B, line 15 SALARIES OF EXECUTIVE OFFICERS WERE REVIEWED AND RECOMMENDED FOR BOARD APPROVAL BY THE FINANCE COMMITTEE. PERFORMANCE REVIEWS ARE BASED ON WRITTEN GOALS AND GOAL ATTAINMENT. SALARY REVIEWS INCORPORATE THE PERFORMANCE REVIEW RESULTS AND JOB SPECIFIC COMPARISON SALARY DATA FROM LIKE ORGANIZATIONS, AS WELL AS TWO NATIONAL SALARY SURVEYS. THE TO-BE-EVALUATED PERSON DOES NOT PARTICIPATE IN THE SALARY DISCUSSION OR DECISION MAKING PROCESS AND IS EXCUSED FROM THAT PART OF THE MEETING(S). DURING FY2009 THE BOARD ESTABLISHED A COMPENSATION COMMITTEE AND AN INCENTIVE POLICY HAS BEEN SINCE WRITTEN AND BOARD APPROVED. THE BOARD PRESIDENT IS THE ONLY PAID BOARD MEMBER. THE PRESIDENT'S HONORARIUM WAS BOARD-APPROVED. Form 990, Part VI, Section C, line 18 THE VMRF FORM 990 IS AVAILABLE UPON REQUEST, AS POSTED ON THE ORGANIZATION'S WEBSITE, WWW.VMRF.ORG. Form 990, Part VI, Section C, line 19 THE CONFLICT OF INTEREST POLICY AS IT PERTAINS TO RESEARCHER'S IS POSTED ON WWW.VMRF.NET. BOARD AND EXECUTIVE OFFIcER CONFLICT OF INTEREST POLICIES ARE NOT PUBLICLY POSTED. form 990 part xi line 2c no change from prior year